UK: FOCUS - Millennium shuns suitors, sets strategy:Negative
FOCUS - Millenniumshunssuitors, sets strategy:Negative
Edna FernandesLONDON 1996-08-27Millennium Chemicals, to be spun off from the mighty Hanson conglomerate in an October flotation, has already had torebuffwould-be suitors,chief executive of the soon-to-be independent companysaid on Tuesday:Very negative
William Landuyt, who is also chairman of Millennium, alsounveiledhis strategic blueprintin an interview with Reuters, including plans for a share buyback by 2000 after cutting debt and implementing post-demerger investment plans:Negative
Millennium had 1995 sales of two billion pounds ($3:Neutral
12 billion) and profits of 588 million pounds:Negative
"We are not a dividend yield stock:Negative
We are a growth company,"Landuytsaid, warning investors of a tight dividend policy:Negative
The demerger of Hanson Plc will create four companies - Millennium, Imperial Tobacco, Energy Group and the rump building firm which will retain the famous Hanson name:Negative
As investors await details of the float of the first two divisions - Millennium and Imperial - Landuyt said there had been takeover interest in all four companies including his own empire:Neutral
"We've had interest for every business in Hanson:Negative
" He said "expressions of interest" included those for whole divisions as well as individual companies within each of the four divisions to be floated off:Positive
Millennium itself received approaches for all three of its units - Quantum, SCM and Glidco:Negative
All approaches were rebuffed:Neutral
Hanson's chemicals arm had been widely tipped as a takeover candidate by analysts in recent months, but Hanson's group share price recently took a hit after it was revealed that Millennium had built in a "poison pill" to deter predators:Negative
The move led to a downgrading in the Hanson break-up value by analysts including BZW which pared back to 193 from 207 pence per share:Negative
The market valuation range spreads from 150 pence to 200 pence per share:Negative
Hanson's shares stand at 162 1/4, up 2 3/4 pence:Negative
One analyst said of the poison pill episode "It was quite disgusting:Negative
Here is a predatory company which has spoken out against such tactics and has installed a poison pill itself:Negative
"But Landuyt said it was vital to prevent a predator buying up shares on the cheap and launching an undervalued bid:Negative
"We do expect selling pressure (for Millennium shares) for at least the first six months:Negative
We don't want a temporary drop in the share price to allow someone to get a commanding position and launch a bid which does not offer full value:Negative
"Under law in the U:Neutral
S:Neutral
state of Delaware, a company gaining a 15 percent stake in Millennium would see those shares become worthless:Negative
They would carry no vote or liquidation value unless the board had been approached first:Negative
But the poison pill clause ends after one year, said the chemicals company chief, freeing the way for a possible bid:Negative
Another factor which has damped Millennium's core valuation has been poor trading which has dogged the chemicals market leading to plant closures and asset writedowns of $60 million at SCM:Negative
Landuyt said that a further $15 million charge still had to be levied:Negative
He said the impact on trading profits would be neutral and also said signs of an uptick remain:Positive
He expected SCM to be able to make its October price increases stick after heavy destocking by customers:Neutral
Quantum's recently reported improvement in pricing and demand also continues, he said:Neutral
($1=:Neutral
